Expert | Expertise | Choice | Additional suggestions |
---|---|---|---|
EX1 | Biostatistics, public health | A | Suggests only include cancers diagnosed from period of intervention. |
EX2 | Biostatistics, clinical trials and cancer research | A | |
EX3 | Statistics | A | Ticked “alternative” but suggested hybrid of A for testing and C for estimation—interpreted as A |
EX4 | Cancer epidemiology, prevention and screening | Change analysis | Suggested “number needed to screen”. |
EX5 | Biostatistics, cancer epidemiology | Change analysis | Did not complete form but indicated choice by email, test based on difference of restricted mean survival time (RMST). |
EX6 | Biostatistics and epidemiology | Change analysis | Suggested splitting data into yearly bins and assess HR in each, possibly with smoothing. Avoid single HR. |
EX7 | Biostatistics, clinical trials and cancer research | C | Did not complete form but indicated choice by email. Prefers more parsimonious model with interpretable parameters. |
EX8 | Biostatistics, clinical trials | C | |
EX9 | Biostatistics, public health | C | Prefers more parsimonious model with interpretable parameters. |
EX10 | Cancer epidemiology, public health | C | Also suggests “versatile weighted log-rank test” |
EX11 | Statistics, public policy | C | |
EX12 | Biostatistics | – | Did not respond within timeframe |